$INO Recent News Monday's biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 12:00 PM

$INO Recent News

Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein

Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha

Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Investors Face Lawsuit Over Misleading Claims

Investors Land in Hot Water with Ardelyx Alright, folks, here we go again. New York's courtroom dramas are in full swing with Ardelyx, Inc. at center stage, and not in a good way. The DJS Law Group has rallied the troops, reminding investors caught in the storm of a class action lawsuit. Specifically, it's all about alleged violations of the Securities Exchange Act of...

Cecilia Vicuña's Bold Exhibition at MOCA Tackles Water Crisis

Art and ecological awareness dance together on a tightrope at the Museum of Contemporary Art (MOCA) in Los Angeles. Cecilia Vicuña’s new exhibition, The Dream of Water: Quipu of Encounters Maricunga, arrives with a punch, not merely as art but as a call to arms for water conservation and environmental justice. The show kicks off on November 15, 2026, and remains open...

Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Doximity Faces Legal Fire: Investor Stakes at Risk

Doximity's Legal Storm: A Rocky Road Ahead? Here's the deal, folks. Doximity, a name some might've thrown around in digital health conclaves, is now wrapped up in a mire of legal woes. Those tricky waters come courtesy of a securities class action lawsuit—all about overstated growth prospects that took some investors by surprise. What's Got Investors Peeved? Investors...

Valmet Fuels Century Sunshine's Pulp Revolution

Valmet's Bold Move in China's Pulp Industry Alright, let's dive deep into this pulp mill saga. Valmet isn't some novice in the industrial playing field, and their latest venture is a testament to that. They've clinched a hefty deal exceeding EUR 100 million to outfit Century Sunshine's Rizhao pulp mill in Shandong. This isn't just some small-time endeavor; it's a...

Abbott Shines in Q3 2026 with Strong Sales and EPS

Q3 2026: Abbott's Strategic Moves Pay Off When companies start tossing around terms like 'strong third-quarter results,' ears perk up—especially mine. Abbott (NYSE: ABT) gave us something to chew on with their Q3 2026 earnings, flexing a solid 14.5% reported sales growth. Hey, let’s not forget about the substantial comparable sales growth of 7.0%. They’re waving...

Advent Expands Middle East Presence with Abu Dhabi Office

Advent's Bold Middle East Move Alright, let's get one thing straight: Advent isn't just tiptoeing into the Middle East—they're making a splash. On October 21, 2026, Advent unfurled a shiny new office in Abu Dhabi's ADGM, a prime international financial center. This ain't some tentative handshake. This move boldly asserts their ambition to deepen their foothold with...

Selling Montana Cabins: Tips from Shawna Norry

Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...

CAR T-Cell Therapy Offers New Hope for SPS Patients

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Sun Home Saunas Earns Top Workplace Honors in Retail

In an age where corporate values often seem like lip service, Sun Home Saunas is showing the world what truly being a great place to work means—and they're getting recognized for it. Fortune has placed the sauna and cold plunge company at No. 17 on its 2026 Best Workplaces in Retail list. This ain't just fluff. We're talking about real employees, 100% of them, touting...